Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Spain Pharmaceuticals and Healthcare Report Q1 2008

Published by: Business Monitor International

Published: Feb. 1, 2008 - 73 Pages


Table of Contents


Executive Summary
Spain: Pharmaceutical And Healthcare Industry SWOT
Spain Economic SWOT
Pharmaceutical Business Environment Ratings
Pharmaceutical Ratings - Revised Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Spain - Business Environment Rating
Table: Business Environment Rankings
Western Europe Regional Review
Spain - Market Summary
Regulatory Regime
Intellectual Property Issues
Pricing And Reimbursement Issues
Table: Timeline - Spain's Pharmaceutical Pricing Reforms
Price Cut On Older Drugs
Reference Pricing System
Industry Reaction
Parallel Trade
Industry Developments
Foreign Sector
Generics Sector
Indigenous Manufacturing Sector
Research Sector Developments
Table: Firms Active In Nanofarma Consortium
Government Investment
Industry Forecast Scenario
Overall Market Forecast
Table: Spain’s Drug Market Forecast Indicators
Table: Spain’s Health Expenditure Forecast Indicators
Key Growth Factors - Industry
Key Growth Factors - Macroeconomic
Table: Spain - Macroeconomic Forecasts
Prescription Market Forecast
Table: Spain’s Prescription Drugs Market Forecast Indicators (US$mn unless otherwise stated)
OTC Market Forecast
Table: Spain’s OTC Market Forecast Indicators (US$mn unless otherwise stated)
Generics Market Forecast
Table: Spain’s Generics And Branded Market Forecast Indicators
Export/Import Forecast
Table: Pharmaceutical Trade Indicators (US$mn)
Competitive Landscape
Retail Market
Manufacturers
Table: Leading Pharmaceutical Manufacturers In Spain
Company Profiles
Leading Multinational Manufacturers
GlaxoSmithKline (GSK)
Pfizer
Novartis
Sanofi-Aventis
Merck & Co
Indigenous Manufacturers
Almirall Prodesfarma
Dr Esteve
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources

Abstract

Spain’s drug market is growing at a sluggish pace and was worth US$16.18bn in 2006. Over theremainder of the forecast period BMI expects a compound annual growth rate (CAGR) of 2.65%, bringtotal sector value to US$18.9bn, although the new reference pricing system and a subsequent drop inmedicine prices will have a deflationary impact. As shown in this Spain Q108 Pharmaceuticals &Healthcare Report, growth should be higher in the generics sector, with sales expanding above overallmarket expectations, albeit from a smaller base.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008